Have your own idea? Try our Stock Screener
Polish (WIG) Biotech Industry Analysis
UpdatedApr 03, 2026
DataAggregated Company Financials
Companies13
- 7D2.2%
- 3M3.3%
- 1Y-2.6%
- YTDn/a
Last week, the Biotech industry hasn't moved much but Bioceltix is up 13% in that time. Unfortunately though, the industry is down 3.5% over the past 12 months. As for the next few years, earnings are expected to grow by 48% per annum.
Industry Valuation and Performance
Has the Polish Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 03 Apr 2026 | zł2.0b | zł353.9m | -zł150,930,751.00 | 79.3x | -13.1x | 5.6x |
| Sun, 01 Mar 2026 | zł2.0b | zł429.9m | -zł152,630,978.00 | 67.6x | -13.3x | 4.7x |
| Tue, 27 Jan 2026 | zł2.0b | zł427.5m | -zł155,672,238.00 | 48.4x | -13x | 4.7x |
| Thu, 25 Dec 2025 | zł1.8b | zł427.5m | -zł155,672,238.00 | 46.2x | -11.7x | 4.3x |
| Sat, 22 Nov 2025 | zł1.8b | zł427.7m | -zł158,415,044.00 | 45.9x | -11.6x | 4.3x |
| Mon, 20 Oct 2025 | zł1.9b | zł394.6m | -zł166,699,765.00 | 38.2x | -11.6x | 4.9x |
| Wed, 17 Sep 2025 | zł2.0b | zł400.7m | -zł143,324,812.00 | 41.6x | -13.7x | 4.9x |
| Fri, 15 Aug 2025 | zł2.1b | zł402.5m | -zł140,521,881.00 | 47.2x | -14.8x | 5.2x |
| Sun, 13 Jul 2025 | zł2.0b | zł401.8m | -zł140,766,468.00 | 33x | -14.5x | 5.1x |
| Tue, 10 Jun 2025 | zł2.1b | zł398.2m | -zł145,311,212.00 | 49.3x | -14.4x | 5.2x |
| Thu, 08 May 2025 | zł2.1b | zł425.0m | -zł113,104,193.00 | 54.4x | -18.7x | 5x |
| Sat, 05 Apr 2025 | zł1.9b | zł438.8m | -zł95,426,193.00 | 31x | -20.2x | 4.4x |
| Mon, 03 Mar 2025 | zł2.1b | zł438.6m | -zł94,885,631.00 | 29.8x | -21.7x | 4.7x |
| Wed, 29 Jan 2025 | zł1.9b | zł408.7m | -zł84,434,269.00 | 42.2x | -22.9x | 4.7x |
| Fri, 27 Dec 2024 | zł1.8b | zł408.7m | -zł84,434,269.00 | 39.5x | -21.4x | 4.4x |
| Sun, 24 Nov 2024 | zł1.9b | zł407.6m | -zł85,383,772.00 | 39.2x | -22.2x | 4.7x |
| Tue, 22 Oct 2024 | zł2.1b | zł438.7m | -zł64,845,969.00 | 62.4x | -33.1x | 4.9x |
| Thu, 19 Sep 2024 | zł2.1b | zł442.8m | -zł53,453,784.00 | 62.8x | -39.5x | 4.8x |
| Sat, 17 Aug 2024 | zł2.2b | zł443.9m | -zł63,570,104.00 | 74x | -34x | 4.9x |
| Mon, 15 Jul 2024 | zł2.2b | zł444.2m | -zł64,230,755.00 | 71x | -33.8x | 4.9x |
| Wed, 12 Jun 2024 | zł2.0b | zł439.7m | -zł90,277,755.00 | 71x | -22.2x | 4.6x |
| Fri, 10 May 2024 | zł2.2b | zł441.3m | -zł90,006,665.00 | 55.4x | -24.6x | 5x |
| Sun, 07 Apr 2024 | zł2.2b | zł432.0m | -zł73,964,007.00 | 61.4x | -29.7x | 5.1x |
| Tue, 05 Mar 2024 | zł2.3b | zł462.1m | -zł74,341,007.00 | 56.9x | -30.9x | 5x |
| Thu, 01 Feb 2024 | zł2.7b | zł499.9m | -zł66,755,911.00 | 86.1x | -40.3x | 5.4x |
| Sat, 30 Dec 2023 | zł2.7b | zł499.9m | -zł66,755,911.00 | 87x | -40.6x | 5.4x |
| Mon, 27 Nov 2023 | zł2.6b | zł498.2m | -zł58,578,911.00 | 97.8x | -43.7x | 5.1x |
| Wed, 25 Oct 2023 | zł2.7b | zł518.4m | -zł60,859,678.00 | 46.4x | -44.4x | 5.2x |
| Fri, 22 Sep 2023 | zł2.8b | zł518.5m | -zł61,744,678.00 | 49.8x | -44.7x | 5.3x |
| Sun, 20 Aug 2023 | zł2.8b | zł520.3m | -zł43,292,668.00 | 51.6x | -64.5x | 5.4x |
| Tue, 18 Jul 2023 | zł2.9b | zł520.7m | -zł42,515,291.00 | 55.8x | -68.9x | 5.6x |
| Thu, 15 Jun 2023 | zł2.9b | zł517.3m | -zł42,548,721.00 | 62.3x | -67.2x | 5.5x |
| Sat, 13 May 2023 | zł2.9b | zł520.8m | -zł42,603,826.00 | 65.9x | -69.2x | 5.7x |
| Mon, 10 Apr 2023 | zł2.8b | zł492.9m | -zł11,631,449.00 | 59.7x | -242.9x | 5.7x |
Price to Earnings Ratio
-242.9x
Current Industry PE
- Investors are optimistic on the Polish Biotechnology industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 5.0x is lower than the industry's current PS ratio of 5.6x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
- Revenues have also declined 10% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does Polish Biotech compare with similar industries?
| PL Market | 3.70% | |
| Healthcare | -1.31% | |
| Biotech | 2.20% | |
| Biotech | 2.20% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BCX Bioceltix | zł82.60 | 13.2% +zł47.3m | -17.7% | PB15.1x | |
| CTX Captor Therapeutics Spolka Akcyjna | zł80.80 | 2.3% +zł10.0m | 109.9% | PS59x | |
| BIO BIOTON | zł4.30 | 2.4% +zł8.6m | 16.8% | PE108.8x | |
| SVE Synthaverse | zł3.68 | 1.7% +zł4.2m | -19.7% | n/a | |
| GEN Genomed Spólka Akcyjna | zł25.80 | 6.6% +zł2.1m | n/a | PE10.2x |